2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology

Abstract

Purpose To update the ASCO/Oncology Nursing Society (ONS) Chemotherapy Administration Safety Standards and to highlight standards for pediatric oncology. Methods The ASCO/ONS Chemotherapy Administration Safety Standards were first published in 2009 and updated in 2011 to include inpatient settings. A subsequent 2013 revision expanded the standards to include the safe administration and management of oral chemotherapy. A joint ASCO/ONS workshop with stakeholder participation, including that of the Association of Pediatric Hematology Oncology Nurses and American Society of Pediatric Hematology/Oncology, was held on May 12, 2015, to review the 2013 standards. An extensive literature search was subsequently conducted, and public comments on the revised draft standards were solicited. Results The updated 2016 standards presented here include clarification and expansion of existing standards to include pediatric oncology and to introduce new standards: most notably, two-person verification of chemotherapy preparation processes, administration of vinca alkaloids via minibags in facilities in which intrathecal medications are administered, and labeling of medications dispensed from the health care setting to be taken by the patient at home. The standards were reordered and renumbered to align with the sequential processes of chemotherapy prescription, preparation, and administration. Several standards were separated into their respective components for clarity and to facilitate measurement of adherence to a standard. Conclusion As oncology practice has changed, so have chemotherapy administration safety standards. Advances in technology, cancer treatment, and education and training have prompted the need for periodic review and revision of the standards. Additional information is available at http://www.asco.org/chemo-standards .

Pregnancy Screening in Patients With Cancer

“…11 Due to the harm cancer treatment can have on a fetus and the high possibility of unplanned pregnancy in WOCBPs, regular pregnancy screening and testing is recommended. 12 ASCO/Oncology Nursing Society (ONS) Chemotherapy Administration Safety Standards 13 inform overall treatment planning, and do not explicitly recommend pregnancy testing for WOCBPs before beginning cancer treatment such as chemotherapy and radiation. Instead, these organizations have general guidelines that recommend a complete medical history and essential workup of each patient to include pregnancy status when appropriate.…”

Patient Safety in the Administration of Antineoplastic Chemotherapy and of Immunotherapics for Oncological Treatment: Scoping Review

“…Regarding the journals, two had published seven (14.9%) articles in the Clin J Oncol Nurs [6][7]18,[27][28][34][35] (impact factor 0.881, Journal Citation Reports 2017-2018), six (12.8%) studies in the Oncol Nurs Forum 9,17,20,22,26,52 (impact factor 1.785, Journal Citation Reports 2017-2018), five (10.6%) in the J Oncol Pract 4,17,38,40,45 (impact factor 2.509, Journal Citation Reports 2017-2018) and in the Eur J Oncol Nurs 23,44,46,48,51 (impact factor 1.812, Journal Citation Reports 2017-2018), three (6.4%) publications in the J Pediatr Oncol Nurs 5,30,32 (impact factor 1.294, Journal Citation Reports 2017-2018), two (4.3%) in the Qual Saf Health Care 25,29 (according to the latest data, not indexed in the Journal Citation Reports). The other studies were published in different health journals.…”

“…The other studies were published in different health journals. 3,[13][14][15][16]19,21,[24][25]31,33,43,[36][37]39,42,47,[49][50] The safety of cancer drug administration in adults, children and young people in hospitals, [3][4][6][7][13][14][15][16][17][18][19][20][21][22]27,33,[35][36][40][41]44,[47][48][49][50]52 outpatient clinics, [3][4][5][16][17][18][19...…”

“…According to its purpose, CTX can be classified as adjuvant, following curative surgery; neoadjuvant, indicated for partial tumor reduction; curative, used to achieve complete tumor control; and palliative, which aims to minimize the symptoms arising from tumor proliferation with increased survival. [3][4][5] In addition to CTX, surgery, radiotherapy, (teletherapy and brachytherapy), other treatmentssuch as hormone therapy, immunotherapy, nanotechnology, and gene and molecular therapies -are used to treat some types of tumors. These techniques can be employed alone or in combination to provide better results.…”

Tempo padrão das intervenções de enfermagem em ambulatório de quimioterapia adulto

“…Segundo "To update the American Society of Clinical Oncology (ASCO ) / Oncology Nursing Society (ONS) Chemotherapy Administration Safety Standards and to highlight standards for pediatric oncology (2016)" 51 , os quimioterápicos são divididos em classes que incluem: agentes alvo, agentes alquilantes, antimetabólitos, alcalóides e terpenóides de plantas, inibidores de topoisomerase, antibióticos antitumorais, anticorpos monoclonais, agentes biológicos, além de agentes relacionados.…”